Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of Denmark’s economic growth.
Previous Story
Tech Chiefs to Gather in Washington Next Month on A.I. Regulations
Next Story
U.S. and China Agree to Broaden Talks in Bid to Ease Tensions
